Burning Rock Biotech Limited (BNR) Gamma Exposure (GEX) & Greeks
Gamma exposure (GEX) analysis shows an assumed dealer book's hedging pressure across strikes (dealers long the calls, short the puts). Beside it: the put-minus-call delta balance (DEX), vanna, charm flow, vomma, and vega exposure.
Burning Rock Biotech Limited (BNR) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $14.0M, listed on NASDAQ, employing roughly 667 people, carrying a beta of 1.29 to the broader market. Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Led by Yusheng Han, public since 2020-06-12.
Greeks exposure analysis shows an assumed dealer book's exposure across strike prices for five Greeks, beside the put-minus-call delta balance. No recent options activity for BNR as of 2026-11-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.
Learn how gamma exposure is reported and how to read the data →